drugset / Trial / NCT00152022

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

NCT00152022 ↗

Phase 3 Completed 412 enrolled Shire
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and effectiveness of SPD465 compared to placebo (a capsule with no medication in it) in the treatment of ADHD. The study will also look at how SPD465 affects the participants sleep and how they perceive their quality of life.

Timeline

Start
2005-04-25
Primary completion
2005-11-04
Completion
2005-11-04

Drugs

EvaluationDrugModalityDoseRoute
Subject SPD465 Unknown — —